Specific Determination and Identification of Cross-Linked Fibrin Degradation Products in Patients Under Thrombolytic Therapy for Myocardial Infarction

Publisher Website
Google Scholar
Abstract
We have demonstrated that the specific determination and identification of plasma FbDP alone is not sufficient to follow the effectiveness of thrombolytic therapy. Some patients who received an intravenous infusion of rt-PA for myocardial infarction had very high plasma FbDP levels, although no recanalization was observed angiographically. Since in many cases the FbDP levels increased after recanalization, it is assumed that rethrombosis may occur during and after t-PA treatment.

This publication has 0 references indexed in Scilit: